6533b853fe1ef96bd12ac347
RESEARCH PRODUCT
Cytotoxicity of fagaramide derivative and canthin-6-one from Zanthoxylum (Rutaceae) species against multidrug resistant leukemia cells
Eric KorirRuth Anyango OmoleMatthias HeydenreichEan-jeong SeoGacheru Martin MbogoJacob O. MidiwoLeonidah Kerubo OmosaAbiy YenesewThomas A. Efferthsubject
biologyOrganic ChemistryResazurinPlant Sciencemedicine.diseasebiology.organism_classificationBiochemistryMolecular biologyAnalytical ChemistryMultiple drug resistanceLeukemiachemistry.chemical_compoundchemistryZanthoxylumSesaminmedicineCytotoxic T cellCytotoxicityLupeoldescription
In our continuous search for cytotoxic compounds from the genus Zanthoxylum, chromatographic separation of the MeOH/CH2Cl2 (1:1) extract of Z. chalybeum yielded one new alkamide; 4-(isoprenyloxy)-3-methoxy-3,4-deoxymethylenedioxyfagaramide (1) and a known one; fagaramide (2). Similarly, from the MeOH/CH2Cl2 (1:1) extract of the stem bark of Z. parachanthum four known compounds; canthin-6-one (3), dihydrochelerythrine (4), lupeol (5) and sesamin (6) were isolated. Characterization of the structures of these compounds was achieved using spectroscopic techniques (NMR and MS). Using resazurin reduction assay 1, 3 and 6 displayed moderate cytotoxicity with IC50 values below 50 μM against the drug sensitive CCRF-CEM and multidrug-resistant CEM/ADR5000 leukemia cell lines. It is interesting to note that 3 was more active than the standard drug, doxorubicin against CEM/ADR5000 leukemia cells. Compounds 3 and 6 showed good selectivity on leukemia cells than normal cells. In future studies 3 should be tested against a panel of drug resistant human cells.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2019-03-21 |